EUROPACE

metrics 2024

Pioneering insights for better patient outcomes.

Introduction

EUROPACE, published by Oxford University Press, stands at the forefront of cardiovascular and physiological research, as evidenced by its prestigious Q1 categorization in both Cardiology and Cardiovascular Medicine and Physiology (medical) for 2023. With an impressive ranking of #39 out of 387 and #14 out of 113 in the relevant Scopus categories, EUROPACE is recognized for its rigorous peer-reviewed articles that significantly contribute to advancing knowledge in heart rhythm disorders and related approaches. The journal has been operational since 1999 and will continue shaping the future of cardiovascular research until 2024, making it a vital resource for researchers, clinicians, and students alike. Through its commitment to disseminating high-quality research, EUROPACE plays a crucial role in enhancing the understanding and treatment of cardiac conditions, thereby influencing clinical practice and improving patient outcomes across the globe.

Metrics 2024

SCIMAGO Journal Rank2.90
Journal Impact Factor7.90
Journal Impact Factor (5 years)6.30
H-Index128
Journal IF Without Self7.90
Eigen Factor0.02
Normal Eigen Factor4.79
Influence2.02
Immediacy Index2.40
Cited Half Life5.30
Citing Half Life5.20
JCI1.82
Total Documents6887
WOS Total Citations15769
SCIMAGO Total Citations54658
SCIMAGO SELF Citations6180
Scopus Journal Rank2.90
Cites / Document (2 Years)4.80
Cites / Document (3 Years)4.50
Cites / Document (4 Years)4.15

Metrics History

Rank 2024

Scopus

Cardiology and Cardiovascular Medicine in Medicine
Rank #39/387
Percentile 89.92
Quartile Q1
Physiology (medical) in Medicine
Rank #14/113
Percentile 87.61
Quartile Q1

IF (Web Of Science)

CARDIAC & CARDIOVASCULAR SYSTEMS
Rank 19/220
Percentile 91.60
Quartile Q1

JCI (Web Of Science)

CARDIAC & CARDIOVASCULAR SYSTEMS
Rank 25/220
Percentile 88.64
Quartile Q1

Quartile History

Similar Journals

HEART RHYTHM

Exploring the heartbeat of medical breakthroughs.
Publisher: ELSEVIER SCIENCE INCISSN: 1547-5271Frequency: 12 issues/year

HEART RHYTHM is a leading academic journal published by Elsevier Science Inc, focusing on cutting-edge research in the field of cardiology and cardiovascular medicine. Established in 2004 and continuing its impactful journey through 2024, this journal holds an esteemed position within the academic community, boasting a 2023 Q1 ranking in both Cardiology and Cardiovascular Medicine and Medical Physiology, indicating its significant influence and contribution to these areas of study. With a commendable Scopus ranking—ranked #34 out of 387 in Cardiology and #11 out of 113 in Physiology—HEART RHYTHM is recognized for publishing high-quality research that drives advancements in understanding heart rhythms and associated medical conditions. Although it does not support open access, the journal remains accessible to professionals, researchers, and students, serving as a vital resource for the latest findings and theories in cardiovascular health. Invested in the mission to enhance knowledge and improve clinical practices, HEART RHYTHM stands as an essential publication for those aspiring to excel in the fields of cardiology and cardiovascular research.

Annals of Pediatric Cardiology

Innovating Care for Children's Hearts, One Study at a Time
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0974-2069Frequency: 3 issues/year

Annals of Pediatric Cardiology is a distinguished peer-reviewed journal published by Wolters Kluwer Medknow Publications, focusing on the critical intersection of cardiology and pediatric health. Since its inception in 2008 as an Open Access journal, it has been at the forefront of disseminating significant research findings, clinical practices, and advancements in the field of pediatric cardiology. With an ISSN of 0974-2069 and an E-ISSN of 0974-5149, this journal is crucial for researchers, clinicians, and students seeking to enhance their knowledge in cardiological care for children. The journal's impact is underscored by its presence in the Q3 quartile in both Cardiology and Cardiovascular Medicine and Pediatrics, Perinatology, and Child Health categories for 2023, demonstrating its relevance in contemporary medical research. Operating out of India, the journal addresses a gap in pediatric cardiology literature, offering a platform for high-quality research and case studies that inform clinical practice and policy.

Annals of Cardiothoracic Surgery

Exploring New Frontiers in Heart and Lung Surgery
Publisher: AME PUBLISHING COMPANYISSN: 2225-319XFrequency: 6 issues/year

Annals of Cardiothoracic Surgery is a premier academic journal published by AME Publishing Company, dedicated to advancing the field of cardiology and cardiovascular medicine, as well as surgery. With a focus on innovative research and clinical practices, this journal has established a strong presence within the academic community, holding a commendable Q2 ranking in both cardiology and surgery categories as of 2023. The journal primarily functions as a platform for researchers, clinicians, and healthcare professionals to disseminate groundbreaking studies, case reports, and reviews that shape future surgical techniques and cardiothoracic interventions. While it operates as a non-open-access publication, its commitment to fostering high-quality research makes it an invaluable resource for anyone invested in the evolving landscape of cardiothoracic surgery. Established in 2016, the journal continues to publish impactful findings with relevance extending to current and future practices in the field. Operating out of Hong Kong, its international reach emphasizes a global perspective on cardiothoracic surgical advancements.

Cardiology Research and Practice

Advancing cardiovascular knowledge for a healthier tomorrow.
Publisher: HINDAWI LTDISSN: 2090-8016Frequency: 1 issue/year

Cardiology Research and Practice is a leading academic journal dedicated to advancing knowledge in the fields of cardiology and cardiovascular medicine. Published by HINDAWI LTD, this journal has been an inclusive platform for open access research since 2009, facilitating the dissemination of high-quality studies that contribute to the global scientific community. With an impact factor placing it in Q2 of its category in 2023, it underscores its importance in delivering innovative insights and discoveries that shape clinical practices and policies. The journal covers a broad scope of topics including, but not limited to, cardiovascular disease prevention, innovative treatment modalities, and emerging technologies, appealing to researchers, healthcare professionals, and students alike. Located in the United States with its international reach, Cardiology Research and Practice serves as a critical resource for those dedicated to improving patient outcomes and advancing the field of cardiology.

HEART AND VESSELS

Transforming Heart Health Through Scholarly Excellence
Publisher: SPRINGERISSN: 0910-8327Frequency: 12 issues/year

HEART AND VESSELS is a prominent peer-reviewed journal published by SPRINGER, dedicated to advancing the fields of cardiology and cardiovascular medicine. With its ISSN 0910-8327 and E-ISSN 1615-2573, this esteemed journal encompasses a broad range of topics pertinent to heart health, vascular function, and associated therapies, making it an essential resource for researchers, clinicians, and healthcare professionals alike. Based in Japan and operating since 1985, HEART AND VESSELS has consistently maintained a Q2 ranking in the 2023 category quartiles, highlighting its relevance and impact in the cardio domain. Although it does not offer open access, the journal ensures high-quality publications that contribute significantly to the academic and clinical understanding of cardiovascular health. With over three decades of continuous scholarly contribution, HEART AND VESSELS serves as a vital platform for disseminating cutting-edge research and fostering innovative practices in the management of cardiovascular diseases.

Heart Rhythm O2

Bridging science and practice in heart rhythm management.
Publisher: ELSEVIERISSN: 2666-5018Frequency: 6 issues/year

Heart Rhythm O2, published by Elsevier and indexed under ISSN 2666-5018, is a premier Open Access journal that has established itself as a vital platform for the dissemination of innovative research in Cardiology and Cardiovascular Medicine. Since its inception in 2020, this journal has rapidly gained recognition, achieving a distinguished Q1 ranking in its field as of 2023, underscoring its commitment to excellence and quality. Operating from its base in the Netherlands, Heart Rhythm O2 aims to bridge the gap between clinical practice and emerging scientific findings, fostering collaboration among researchers, healthcare professionals, and students globally. With a focus on high-impact original research, review articles, and clinical studies, the journal is dedicated to advancing our understanding of cardiac rhythm management and cardiovascular health. With open access options, it ensures that vital knowledge is freely available, facilitating the ongoing education and engagement of the medical community worldwide.

JACC-Clinical Electrophysiology

Transforming Clinical Practice with Cutting-Edge Findings
Publisher: ELSEVIERISSN: 2405-500XFrequency: 14 issues/year

JACC-Clinical Electrophysiology, published by Elsevier, stands as a leading journal in the fields of Cardiology and Physiology, with an esteemed Q1 ranking in both categories as of 2023. With an ISSN of 2405-500X and E-ISSN 2405-5018, this journal serves as an essential platform for disseminating cutting-edge research, clinical studies, and innovative practices related to electrophysiological aspects of cardiovascular health. Established in 2015, JACC-Clinical Electrophysiology has attracted high-quality submissions, reflected in its strong presence on Scopus, ranking 41st out of 387 in Cardiology and 15th out of 113 in Physiology (medical), placing it in the 89th and 87th percentiles respectively. Though it operates on a subscription model, its commitment to high standards of peer-reviewed scholarship makes it an indispensable resource for researchers, clinicians, and students dedicated to advancing knowledge and practice in electrophysiology and its impact on cardiac care. Join the community of leaders in the field by engaging with the latest findings and discussions published in this prestigious journal.

Revista Portuguesa de Cardiologia

Empowering the fight against heart disease through open access research.
Publisher: ELSEVIER ESPANA SLUISSN: 0870-2551Frequency: 12 issues/year

Revista Portuguesa de Cardiologia, published by Elsevier España SLU, stands as a pivotal resource in the realm of Cardiology and Cardiovascular Medicine. With its origins tracing back to 1970, this journal has cultivated a robust academic presence, achieving a 2023 Q3 ranking in its category, and currently holding a position of #220 out of 387 on the Scopus rankings, placing it within the 43rd percentile of its field. This open access journal, available since 2011, aims to disseminate high-quality research and insights relevant to contemporary cardiovascular issues. Its commitment to accessibility and knowledge exchange enhances its importance for clinicians, researchers, and students alike, fostering a more informed community in the fight against cardiovascular diseases. Operating from its base in Barcelona, Spain, the journal welcomes contributions that further the understanding and treatment of heart conditions, contributing significantly to the advancement of cardiovascular health.

KARDIOLOGIYA

Bridging Research and Practice in Cardiology
Publisher: RUSSIAN HEART FAILURE SOCISSN: 0022-9040Frequency: 12 issues/year

KARDIOLOGIYA is a renowned academic journal in the field of cardiology, published by the Russian Heart Failure Society. Since its inception in 1961, this journal has been dedicated to disseminating cutting-edge research in cardiovascular medicine, contributing to the global understanding of heart-related diseases and their management. With a significant publication history that spans over six decades, KARDIOLOGIYA provides a platform for both established researchers and emerging scholars to publish their findings. Despite its current Q4 category ranking in the 2023 Cardiology and Cardiovascular Medicine category, the journal plays a crucial role in promoting regional insights and advancements in cardiology, while striving towards higher visibility and impact within the academic community. While not an open-access journal, the journal is accessible to institutions and professionals in the Russian Federation and beyond, fostering collaboration and knowledge sharing among healthcare professionals. With a Scopus rank of #259 among 387 journals, it is well-positioned to enhance discourse in the field and support the development of innovative approaches to cardiovascular care.

Circulation-Arrhythmia and Electrophysiology

Pioneering insights into arrhythmias and electrical activity.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1941-3149Frequency: 12 issues/year

Circulation-Arrhythmia and Electrophysiology, published by Lippincott Williams & Wilkins, is a premier journal dedicated to advancing the field of cardiology and electrophysiology. With a strong emphasis on clinical and experimental research, this journal serves as a critical platform for disseminating innovative findings concerning arrhythmias and cardiac electrical activity. Operating in a highly competitive academic environment, it boasts an impressive Q1 ranking in key categories such as Cardiology and Cardiovascular Medicine, as well as Physiology (medical), positioning it within the top tier of publications in these fields. Spanning a comprehensive converged period from 2008 to 2024, Circulation-Arrhythmia and Electrophysiology offers researchers and clinicians access to cutting-edge studies that inform best practices and influence treatment protocols. Although it does not provide open access options, it remains invaluable for professionals seeking to enhance their understanding of complex electrophysiological phenomena and contribute to the evolution of cardiovascular care.